Please use this identifier to cite or link to this item:
標題: 以乳鐵蛋白輔助治療貓淋巴球漿細胞性口炎
Lactoferrin as an adjuvant therapeutic agent on feline lymphoplasmacytic stomatitis
作者: 洪一平
Hung, Yi-Ping
關鍵字: 乳鐵蛋白;Lactoferrin;貓淋巴球漿細胞性口炎;feline lymphoplasmacytic stomatitis
出版社: 獸醫學系暨研究所
引用: Addie, D.D., Radford, A., Yam, P.S., Taylor, D.J., 2003. Cessation of feline calicivirus shedding coincident with resolution of chronic gingivostomatitis in a cat. The Journal of Small Animal Practice 44, 172-176. Arnold, R.R., Cole, M.F., McGhee, J.R., 1977. A bactericidal effect for human lactoferrin. Science 197, 263-265. Arzi, B., Murphy, B., Cox, D.P., Vapniarsky, N., Kass, P.H., Verstraete, F.J., 2010. Presence and quantification of mast cells in the gingiva of cats with tooth resorption, periodontitis and chronic stomatitis. Archives of Oral Biology 55, 148-154. Baird, K., 2005. Lymphoplasmacytic gingivitis in a cat. The Canadian veterinary journal. La Revue Veterinaire Canadienne 46, 530-532. Baker, E.N., 1994. Structure and reactivity of transferrins. Advances in Inorganic Chemistry 41, 389-463. Baker, E.N., Baker, H.M., 2005. Lactoferrin molecular structure, binding properties and dynamics of lactoferrin. Cellular and Molecular Life Sciences 62, 2531-2539. Baker, H.M., Anderson, B.F., Baker, E.N., 2004. Dealing with iron: common structural principles in proteins that transport iron and heme. In: Proceedings of the National Academy of Sciences of the United States of America, Washington DC, USA, pp. 3579-3583. Bellei, E., Dalla, F., Masetti, L., Pisoni, L., Joechler, M., 2008. Surgical therapy in chronic feline gingivostomatitis (FCGS). Veterinary Research Communications 32, 231-234. Bennett, R.M., Davis, J., 1982. Lactoferrin interacts with deoxyribonucleic acid: a preferential reactivity with double-stranded DNA and dissociation of DNA–anti-DNA complex. The Journal of Laboratory and Clinical Medicine 99, 127-138. Berlutti, F., Pantanella, F., Natalizi, T., Frioni, A., Paesano, R., Polimeni, A., Valenti, P., 2011. Antiviral properties of lactoferrin-a natural immunity molecule. Molecules 16, 6992-7018. Beutler, B., 2002. LPS in microbial pathogenesis: promise and fulfilment. Journal of Endotoxin Research 8, 329-335. Beutler, B., Moresco, E.M., 2008. The forward genetic dissection of afferent innate immunity. Current Topics in Microbiology and Immunology 321, 3-26. Bulman-Fleming, J.C., Tumer, T.R., Rosenberg, M.P., 2010. Evaluation of adverse events in cats receiving long-term piroxicam therapy for various neoplasms. Journal of Feline Medicine and Surgery 12, 262-268. Chu, B.C., Garcia-Herrero, A., Johanson, T.H., Krewulak, K.D., Lau, C.K., Peacock, R.S., Slavinskaya, Z., Vogel, H.J., 2010. Siderophore uptake in bacteria and the battle for iron with the host; a bird''s eye view. BioMetals 23, 601-611. Clark, S.R., Ma, A.C., Tavener, S.A., McDonald, B., Goodarzi, Z., Kelly, M.M., Patel, K.D., Chakrabarti, S., McAvoy, E., Sinclair, G.D., Keys, E.M., Allen-Vercoe, E., Devinney, R., Doig, C.J., Green, F.H., Kubes, P., 2007. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nature Medicine 13, 463-469. Cole, M.F., Arnold, R.R., Mestecky, J., 1976. Studies with human lactoferrin and streptococcus mutans. In : proceedings of a Workshop on Microbial Aspects of Dental Caries, Washington DC, USA, pp. 359-373. Coutts, A.J., Dawson, S., Willoughby, K., Gaskell, R.M., 1994. Isolation of feline respiratory viruses from clinically healthy cats at UK cat shows. The Veterinary Record 135, 555-556. D''Andrea, A., Rengaraju, M., Valiante, N.M., Chehimi, J., Kubin, M., Aste, M., Chan, S.H., Kobayashi, M., Young, D., Nickbarg, E., Chizzonit, R., Wolf, S.F., Trinchieri, G., 1992. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. The Journal of Experimental Medicine 176, 1387-1398. Dowers, K.L., Hawley, J.R., Brewer, M.M., Morris, A.K., Radecki, S.V., Lappin, M.R., 2010. Association of Bartonella species, feline calicivirus, and felineherpesvirus1infection with gingivostomatitis in cats. Journal of Feline Medicine and Surgery 12, 314-321. Drago, S.M.E., 2006. Actividades antibacterianas de la lactoferrina. Enfermedades Infecciosasy Microbiologia Clinica 26, 58-63. Duarte, D.C., Nicolau, A., Teixeira, J.A., Rodrigues, L.R., 2011. The effect of bovine milk lactoferrin on human breast cancer cell lines. Journal of Dairy Science 94, 66-76. Elizondo, G., Ostrosky-Wegman P., 1996. The effects of metronidazole and its metabolites on histamine immunosuppression activity. Life Science 59, 265-297. Ellison, R.T., Giehl, T.J., Laforce, F.M., 1988. Damage of the membrane of enteric Gram-negative bacteria by lactoferrin and transferring. Infection and Immunity 56, 2774-2781. Femiano, F., Gombos, F., Scully, C., 2003. Oral erosive/ulcerative lichen planus: preliminary findings in an open trial of sulodexide compared with cyclosporin (ciclosporin) therapy. International Journal of Dermatology 42, 308-311. Ferasin, L., 2001. Iatrogenic hyperadrenocorticism in a cat following a short therapeutic course of methylprednisolone acetate. Journal of Feline Medicine and Surgery 3, 87-93. Garcia-Montoya, I.A., Cendon, T.S., Arevalo-Gallegos, S., Rascon-Cruz, Q., 2012. Lactoferrin a multiple bioactive protein: an overview. Biochimica et Biophysica Acta 1820, 226-236. Gruffydd-Jones, T.J., 1991. Gingivitis and stomatitis. In: Consultation in Feline Internal Medicine, First Ed. WB Saunders, Philadelphia, UAS. pp. 397-402. Guilford, W.G., 1996. Diseases of oral cavity and pharynx. In: Strombeck’s Small Animal Gastroenterology, Third ed. W.B. Saunders Company, Philadelphia, USA, pp. 193-194. Hara, K., Ikeda, M., Saito, S., Matsumoto, S., Numata, K., Kato, N., Tanaka, K., Sekihara, H., 2002. Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes. Hepatology Research 24, 228. Harbour, D.A., Howard, P.E., Gaskell, R.M., 1991. Isolation of feline calicivirus and feline herpesvirus from domestic cats 1980 to 1989. The Veterinary Record 128, 77-80. Harley, R., Helps, C.R., Harbour, D.A., Gruffydd-Jones, T.J., Day, M.J., 1999. Cytokine mRNA expression in lesions in cats with chronic gingivostomatitis. Clinical and Diagnostic Laboratory Immunology 6, 471-478. Harley, R., 2003. Feline gingivostomatitis. In Proceedings of the Hill’s European Symposium on Oral Care, Amsterdam, Nederland, PP. 34-41. Harley, R., Gruffydd-Jones, T.J., Day, M.J., 2011. Immunohistochemical characterization of oral mucosal lesions in cats with chronic gingivostomatitis. Journal of Comparative Pathology 144, 239-250. Healey, K.A., Dawson, S., Burrow, R., Cripps, P., Gaskell, C.J., Hart, C.A., Pinchbeck, G.L., Radford, A.D., Gaskell, R.M., 2007. Prevalence of feline chronic gingivo-stomatitis in first opinion veterinary practice. Journal of Feline Medicine and Surgery 9, 373-381. Hennet, P.R., 1997. Chronic gingivo-stomatitis in cats: long term follow-up of 30 cases treated by dental extractions. Journal of Veterinary Dentistry 14, 15-21. Hennet, P.R., Camy, G.A., McGahie, D.M., Albouy, M.V., 2011. Comparative efficacy of a recombinant feline interferon omega in refractory cases of calicivirus-positive cats with caudal stomatitis: a randomised, multi-centre, controlled, double-blind study in 39 cats. Journal of Feline Medicine and Surgery 13, 577-587. Ikeda, M., Sugiyama, K., Tanaka, T., Tanaka, K., Sekiharab, H., Shimotohno, K., Kato, N., 1998. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes. Biochemical and Biophysical Research Communications 245, 549-553. Ikeda, M., Nozakia, A., Sugiyama, K., Tanaka, T., Naganuma, A., Tanaka, K., Sekihara, H., Shimotohno, K., Saito, M., Kato, N., 2000. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells. Virus Research 66, 51-63. Kaliakatsou, F., Hodgson, T.A., Lewsey, J.D., Hegarty, A.M., Murphy, A.G., Porter, S.R., 2002. Management of recalcitrant ulcerative orallichen planus with topical tacrolimus. Journal of the American Academy of Dermatology 46, 35-41. Klein, D., Leutenegger, C.M., Bahula, C., Gold, P., Hofmann-Lehmann, R., Salmons, B., Lutz, H., Gunzburg, W.H., 2001. Influence of preassay and sequence variations on viral load determination by a multiplex real-time reverse transcriptase-polymerase chain reaction for feline immunodeficiency virus. Journal of Acquired Immune Deficiency Syndromes 26, 8-20. Knowles, J.O., Gaskell, R.M., Gaskell, C.J., Harvey, C.E., Lutz, H., 1989. Prevalence of feline calicivirus, feline leukaemia virus and antibodies to FIV in cats with chronic stomatitis. The Veterinary Record 124, 336-338. Kobayashi, S., Sato, R., Aoki, T., Omoe, K., Inanami, O., Hankanga, C., Yamada, Y., Tomizawa, N., Yasuda, J., Sasaki, J., 2008. Effect of bovine lactoferrin on functions of activated feline peripheral blood mononuclear cells during chronic feline immunodeficiency virus infection. The Journal of Veterinary Medical Science 70, 429-435. Lambert, L.A., Perri, H., Halbrooks, P.J., Mason, A.B., 2005. Evolution of the transferrin family: conservation of residues associated with iron and anion binding. Comparative Biochemistry and Physiology-Part B: Biochemistry & Molecular Biology 142, 129-141. Legrand, D., Vigie’, K., Said, E.A., Elass, E., Masson, M., Slomianny, M.C., Carpentier, M., Briand, J.P., Mazurier, J., Hovanessian, A.G., 2004. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. European Journal of Biochemistry 271, 303-317. Legrand, D., Elass, E., Carpentier, M., Mazurier, J., 2006. Interaction of lactoferrin with cells involved in immune function. Biochemistry and Cell Biology 84, 282-290. Lommer, M.J., Verstraete, F.J., 2003. Concurrent oral shedding of feline calicivirus and feline herpesvirus1 in cats with chronic gingivostomatitis. Oral Microbiology and Immunology 18, 131-134. Lyon, K.F., 1990. The differential diagnosis and treatment of gingivitis in the cat. Problems in Veterinary Medicine and Dentistry 2, 137-151. Lyon, K.F., 2005. Gingivostomatitis. The Veterinary Clinics of North America: Small Animal Practice 35, 891-911. Marchetti, M., Longhi, C., Conte, M.P., Pisani, S., Valenti, P., Seganti, L., 1996. Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells. Antiviral Research 29, 221-231. Marchetti, M., Superti, F., Ammendolia, M.G., Rossi, P., Valenti, P., Seganti, L., 1999. Inhibition of poliovirus type 1 infection by iron-, manganese-, and zinc-saturated lactoferrin. Medical Microbiology and Immunology 187, 199-204. Marr, A.K., Jenssen, H., Moniri, M.R., Hancock, R.E.W., Pante, N., 2009. Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1. Biochimie 91, 160-164. Masson, P.L., Heremans, J.F., Dive, C.H., 1969. An iron-binding protein common to many external secretions. Clinica Chimica Acta 14, 735-739. Oztaş Yeşim, E.R., Ozguneş, N., 2005. Lactoferrin: a multifunctional protein. Advances in Molecular Medicine. 1, 149-154. Park, J.H., Park, G.T., Cho, I.H., Sim, S.M., Yang, J.M., Lee, D.Y., 2011. An antimicrobial protein, lactoferrin exists in the sweat: proteomic analysis of sweat. Experimental Dermatology 20, 369-371. Popovsky, J.L., Camisa, C., 2000. New and emerging therapies for diseases of the oral cavity. Dermatologic Clinics 18, 113-125. Poulet, H., Brunet, S., Soulier, M., Leroy, V., Goutebroze, S., Chappuis, G., 2000. Comparison between acute oral/respiratory and chronic stomatitis/gingivitis isolates of feline calicivirus: pathogenicity, antigenic profile and cross-neutralisation studies. Archives of Virology 145, 243-261. Qiu, J., Hendrixson, D.R., Baker, E.N., Murphy, T.F., St Geme, J.W. 3rd., Plaut, A.G., 1998. Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. In: Proceedings of the National Academy of Sciences of the United States of America, Washington DC, USA, pp. 12641-12646. Reindel, J.F., Trapp, A.L., Armstrong, P.J., Stickle, R.L., 1987. Recurrent plasmacytic stomatitis-pharyngitis in a cat with esophagitis, fibrosing gastritis, and gastric nematodiasis. Journal of the American Veterinary Medical Association 190, 65-67. Reubel, G.H., Hoffmann, D.E., Pedersen, N.C., 1922. Acute and chronic faucitis of domestic cats: a feline calicivirus-induced disease. The Veterinary Clinics of North America: Small Animal Practice 22, 1347-1360. Robson, M., Crystal, M.A., 2011. Gingivitis-Stomatitis-Pharyngitis. In: The Feline Patient, Forth Ed. Blackwell Publishing Ltd., Ames, Iowa, USA, pp. 199-201. Rodriguez, D.A., Vazquez, L., Ramos, G., 2005. Actividad Antimicrobiana de la lactoferrina: Mecanismos and aplicaciones clinicas potenciales. Revista Latinoamericana de Microbiologia 47, 102-111. Sato, R., Inanami, O., Tanaka, Y., Takase, M., Naito, Y., 1996. Oral administration of bovine lactoferrin for treatment of intractable stomatitis in feline immunodeficiency virus (FIV)-positive and FIV-negative cats. American Journal of Veterinary Research 57, 1443-1446. Schanbacher, F.L., Goodman, R.E., Talhouk, R.S., 1993. Bovine mammary lactoferrin: Implications from messenger ribonucleic acid (mRNA) sequence and regulation contrary to other milk proteins. Journal of Dairy Science 76, 3812-3831. Singh, P.K., Parsek, M.R., Greenberg, E.P., Welsh, M.J., 2002. A component of innate immunity prevents bacterial biofilm development. Nature 417, 552-555. Sorensen, M., Sorensen, S.P.L., 1939. The proteins in whey. Comptes rendus des travaux du Laboratoire Carlsberg 23, 55-99. Stuart, J., Norrell, S., Harrington, J.P., 1984. Kinetic effect of human lactoferrin on the growth of Escherichia coli 0111. The International Journal of Biochemistry 16, 1043-1047. Swart, P.J., Kuipers, M.E., Smit, C., Pauwels, R., deBethune, M.P., deClercq, E., Meijer, D.K., Huisman, J.G., 1996. Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro. AIDS Research and Human Retroviruses 12, 769-775. Sykes, J.E., Studdert, V.P., Browning, G.F., 1998. Detection and strain differentiation of feline calicivirus in conjunctival swabs by RT-PCR of the hypervariable region of the capsid protein gene. Archives of Virology 143, 1321-1334. Tenorio, A.P., Franti, C.E., Madewell, B.R., Pedersen, N.C., 1991. Chronic oral infections of cats and their relationship to persistent oral carriage of feline calici-, immunodeficiency, or leukemia viruses. Veterinary Immunology and Immunopathology 29, 1-14. Tiede, I., Fritz, G., Strand, S., Poppe, D., Dvorsky, R., Strand, D., Lehr, H.A., Wirtz, S., Becker, C., Atreya, R., Mudter, J., Hildner, K., Bartsch, B., Holtmann, M., Blumberg, R., Walczak, H., Iven, H., Galle, P.R., Ahmadian, M.R., Neurath, M.F., 2003. CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4t T-lymphocytes. The Journal of Clinical Investigation 111, 1133-1145. Tizard, I.R., 2000. Dendritic cells and antigen processing. In: Veterinary Immunology: An Inroduction, sixth Ed. W.B. Saunders Company, Pennsylvania, Philadelphia, USA, PP.58-68. Torres, J.M., Concepcion, J.L., Vielma, J.R., 2006. Deteccion de lisozima y lactoferrina por western blot en ovas de trucha arcoiris (Oncorhynchus mykiss). Mundo Pecuario 2, 57–59. Truyen, U., Geissler, K., Hirschberger, J., 1999. Tissue distribution of virus replication in cats experimentally infected with distinct feline calicivirus isolates. Berliner und Munchener tierarztliche Wochenschrift 112, 355-358. Unanue, E.R., 1984. Antigen-Presenting Function of the Macrophage. Annual Reviewof Immunology 2, 395-428. Van Der Strate, B.W., Beljaars, L., Molema, G., Harmsen, M.C., Meijer, D.K., 2001. Antiviral ctivities of lactoferrin. Antiviral Research 52, 225-239. Veir J.K., Lappin M.R., Foley J.E., Getzy D.M., 2002. Feline inflammatory polyps: historical, clinical, and PCR findings for feline calicivirus and feline herpes virus-1 in 28 cases. Journal of Feline Medicine and Surgery 4,195-199. Viani, R.M., Gutteberg, T.J., Lathey, J.L., Spector, S.A., 1999. Lactoferrin inhibits HIV-1 replication in vitro and exhibits synergy when combined with zidovudine. AIDS 13, 1273-1274. Vogel, H.J., 2012. Lactoferrin, a bird''s eye view. Biochemistry and Cell Biology 90, 233-244. Wally, J., Buchanan, S.K., 2007. A structural comparison of human serum transferrin and human lactoferrin. BioMetals 20, 249-262. White, S., Rosychuk, R.A.W., Janik, T.A., Denerolle, P., Schultheiss, P., 1992. Plasma cell stomatitis-pharyngitisin cats: 40 cases (1973-1991). Journal of the AmericanVeterinary Medical Association 200, 1377-1380. Williams, C.A., Aller, M.S., 1992. Gingivitis/stomatitis in cats. The Veterinary Clinics of North America: Small Animal Practice 22, 1361-1383.
貓淋巴球漿細胞性口炎 (feline lymphoplasmacytic stomatitis, FLPS) 是一種會造成口腔黏膜具疼痛的糜爛與增生的炎症疾病。罹患FLPS的患貓可能在年幼時就發病,難以痊癒會需要終生依賴藥物的治療。本實驗試驗一種合併乳鐵蛋白口腔噴劑 (bovine lactoferrin oral spray)與piroxicam 的新療法。以隨機雙盲對照實驗 (randomized double-blinded clinical trial)方式進行,對象為13隻罹患FLPS的貓。實驗中以口腔病灶嚴重程度與臨床症狀評分的變化進行藥物療效的評估。全血球計數與血清生化學檢查用於進行麻醉安全性與肝腎功能評估。一系列的口腔黏膜組織採樣,用於檢查在治療前、中、後,組織學下的變化。結果中指出,77 % 的患貓在本實驗的治療下,臨床症狀得到良好的改善。在短期評估中,piroxicam可以在兩週內快速的緩解臨床症狀。而長期評估中,乳鐵蛋白口腔噴劑合併piroxicam可進一步提升治療效果,於12週的治療後,有效緩解口腔病灶(P=0.059),顯著改善臨床症狀(P<0.05)、提升生活品質(P<0.05)、與增加體重(P<0.05)。口腔病灶的改善與黏膜中巨噬細胞數量的減少有顯著相關 (OR 4.719, P<0.05)。此外在12週治療期間,並沒有發現明顯的臨床副作用,或是對肝腎功能的任何影響。總結而言,合併乳鐵蛋白口腔噴劑與piroxicam是安全有效的治療方法,可以作為FLPS的第一線選擇。

Feline lymphoplasmacytic stomatitis (FLPS) is an inflammatory disease that led to painfully erosive lesions and proliferations of the oral mucosa. The FLPS patients may be affected in early age, difficult to be cured, and probably needed a lifetime therapy. In this study, a novel therapeutic modality that combined with bovine lactoferrin (bLf) oral spray and piroxicam was investigated by a randomized double-blinded clinical trial in 13 FLPS patients. The oral lesion grading and symptomatic scoring were performed to assess the clinical outcome during and after the therapy. A CBC and serum chemistry profiles were conducted for the anesthetic safety assessment and the functional evaluation of liver and kidneys. A series of oral mucosa biopsies were used for evaluating the histological changes during, before, and after the treatment. Results indicated that clinical symptoms were well improved in 77 % of FLPS patients. In the short-term (4 weeks) study, the clinical symptoms were significantly ameliorated by oral piroxicam within 2 weeks. In the long- term (12 weeks) study, the combined bLf oral spray and piroxicam could further reinforce the previous effect and lead to a visible amelioration of oral lesions (P=0.059), and a significant improvement of clinical symptoms (P<0.05), quality of life (P<0.05), and weight gain (P<0.05). The remission of oral inflammation was significantly correlated with the decreased number of macrophages in oral mucosa (OR = 4.719, P<0.05). Furthermore, there was neither clinical side-effects nor detectable liver or kidney influence in a 12-week assessment. In conclusion, the combined oral bLf spray and piroxicam was a safe therapeutic method and was suggested as a primary choice of treatment modality for the FLPS patients.
其他識別: U0005-1507201313315000
Appears in Collections:獸醫學系所

Files in This Item:
File Description SizeFormat Existing users please Login
nchu-102-7099038019-1.pdf3.54 MBAdobe PDFThis file is only available in the university internal network   
Show full item record

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.